3,4-Dimethoxycinnamic acidCAS# 2316-26-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 2316-26-9 | SDF | Download SDF |
| PubChem ID | 717531 | Appearance | White powder |
| Formula | C11H12O4 | M.Wt | 208.21 |
| Type of Compound | Phenylpropanoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (E)-3-(3,4-dimethoxyphenyl)prop-2-enoic acid | ||
| SMILES | COC1=C(C=C(C=C1)C=CC(=O)O)OC | ||
| Standard InChIKey | HJBWJAPEBGSQPR-GQCTYLIASA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 3,4-Dimethoxycinnamic acid is a bioavailable coffee component as a perspective anti-prion compound and bind potently to prion protein with a Kd of 405 nM. |
| In vitro | Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption.[Pubmed: 22865606 ]Mol Nutr Food Res. 2012 Sep;56(9):1413-23.This study reports the 24 h human plasma pharmacokinetics of 3,4-Dimethoxycinnamic acid (dimethoxycinnamic acid) after consumption of coffee, and the membrane transport characteristics of certain dimethoxycinnamic acid derivatives, as present in coffee. |
3,4-Dimethoxycinnamic acid Dilution Calculator
3,4-Dimethoxycinnamic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 4.8028 mL | 24.0142 mL | 48.0284 mL | 96.0569 mL | 120.0711 mL |
| 5 mM | 0.9606 mL | 4.8028 mL | 9.6057 mL | 19.2114 mL | 24.0142 mL |
| 10 mM | 0.4803 mL | 2.4014 mL | 4.8028 mL | 9.6057 mL | 12.0071 mL |
| 50 mM | 0.0961 mL | 0.4803 mL | 0.9606 mL | 1.9211 mL | 2.4014 mL |
| 100 mM | 0.048 mL | 0.2401 mL | 0.4803 mL | 0.9606 mL | 1.2007 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- H-Glu(OMe)-OMe.HCl
Catalog No.:BCC2932
CAS No.:23150-65-4
- Oxymetazoline HCl
Catalog No.:BCC4333
CAS No.:2315-02-8
- Pentoxyverine Citrate
Catalog No.:BCC4697
CAS No.:23142-01-0
- Vincosamide
Catalog No.:BCN5081
CAS No.:23141-27-7
- Strictosamide
Catalog No.:BCN5080
CAS No.:23141-25-5
- Physalin B
Catalog No.:BCN7921
CAS No.:23133-56-4
- Heveaflavone
Catalog No.:BCN5079
CAS No.:23132-13-0
- Tectorigenin 7-O-xylosylglucoside
Catalog No.:BCN2903
CAS No.:231288-19-0
- 6'-O-xylosyl-glycitin
Catalog No.:BCN8169
CAS No.:231288-18-9
- Mudanpioside H
Catalog No.:BCC9049
CAS No.:231280-71-0
- 5-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-carbaldehyde
Catalog No.:BCC8719
CAS No.:231278-84-5
- N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine
Catalog No.:BCC9068
CAS No.:231278-20-9
- Pyrolatin
Catalog No.:BCN8439
CAS No.:23176-70-7
- Nervosine
Catalog No.:BCN2012
CAS No.:23179-26-2
- Songoramine
Catalog No.:BCN6474
CAS No.:23179-78-4
- Senkirkine
Catalog No.:BCN2136
CAS No.:2318-18-5
- Simiarenone
Catalog No.:BCN5082
CAS No.:2318-78-7
- Paeoniflorin
Catalog No.:BCN6301
CAS No.:23180-57-6
- Columbianetin acetate
Catalog No.:BCN2652
CAS No.:23180-65-6
- (1R,2S)-2-Amino-1,2-diphenylethanol
Catalog No.:BCC8382
CAS No.:23190-16-1
- Matairesinoside
Catalog No.:BCN7583
CAS No.:23202-85-9
- Ifenprodil hemitartrate
Catalog No.:BCC6688
CAS No.:23210-56-2
- Ifenprodil Tartrate
Catalog No.:BCC4589
CAS No.:23210-58-4
- Doxorubicin
Catalog No.:BCC2082
CAS No.:23214-92-8
Absorption of dimethoxycinnamic acid derivatives in vitro and pharmacokinetic profile in human plasma following coffee consumption.[Pubmed:22865606]
Mol Nutr Food Res. 2012 Sep;56(9):1413-23.
SCOPE: This study reports the 24 h human plasma pharmacokinetics of 3,4-Dimethoxycinnamic acid (dimethoxycinnamic acid) after consumption of coffee, and the membrane transport characteristics of certain dimethoxycinnamic acid derivatives, as present in coffee. METHODS AND RESULTS: Eight healthy human volunteers consumed a low-polyphenol diet for 24 h before drinking 400 mL of commercially available coffee. Plasma samples were collected over 24 h and analyzed by HPLC-MS(2) . Investigation of the mechanism of absorption and metabolism was performed using an intestinal Caco-2 cell model. For the first time, we show that dimethoxycinnamic acid appears in plasma as the free aglycone. The time to reach the C(max) value of approximately 0.5 muM was rapid, T(max) = 30 min, and showed an additional peak at 2-4 h for several subjects. In contrast, smaller amounts of dimethoxy-dihydrocinnamic acid (C(max) approximately 0.1 muM) peaked between 8 and 12 h after coffee intake. In the cell model, dimethoxycinnamic acid was preferentially transported in the free form by passive diffusion, and a small amount of dimethoxycinnamoylquinic acid hydrolysis was observed. CONCLUSION: These findings show that dimethoxycinnamic acid, previously identified in plasma after coffee consumption, was rapidly absorbed in the free form most likely by passive diffusion in the upper gastrointestinal tract.
